APA (7th ed.) Citation

Sabbah, H. N., Gupta, R. C., Kohli, S., Wang, M., Hachem, S., & Zhang, K. (2016). Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure. Circulation. Heart failure, 9(2), e002206. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002206

Chicago Style (17th ed.) Citation

Sabbah, Hani N., Ramesh C. Gupta, Smita Kohli, Mengjun Wang, Souheila Hachem, and Kefei Zhang. "Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure." Circulation. Heart Failure 9, no. 2 (2016): e002206. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002206.

MLA (9th ed.) Citation

Sabbah, Hani N., et al. "Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure." Circulation. Heart Failure, vol. 9, no. 2, 2016, p. e002206, https://doi.org/10.1161/CIRCHEARTFAILURE.115.002206.